We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+66.19%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$455M
AUM Growth
+$57.7M
Cap. Flow
-$82.2M
Cap. Flow %
-18.09%
Top 10 Hldgs %
19.06%
Holding
153
New
50
Increased
18
Reduced
37
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 34.16%
2 Healthcare 25.57%
3 Industrials 23.22%
4 Consumer Discretionary 9.43%
5 Financials 2.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNGE
1
Hinge Health
HNGE
$7.05B
$11.5M 2.54%
139,150
+79,950
+135% +$4.34M
BTSG icon
2
BrightSpring Health Services
BTSG
$11.7B
$10.8M 2.37%
154,620
-34,835
-18% -$1.93M
XMTR icon
3
Xometry
XMTR
$5.39B
$9.74M 2.14%
+100,880
New +$7.21M
SEI
4
Solaris Energy Infrastructure
SEI
$3.28B
$9.23M 2.03%
114,745
-2,570
-2% -$184K
CORT icon
5
Corcept Therapeutics
CORT
$12.3B
$7.97M 1.75%
+91,610
New +$5.53M
DOCN icon
6
DigitalOcean
DOCN
$13.1B
$7.92M 1.74%
50,425
-18,800
-27% -$2.54M
ALGM icon
7
Allegro MicroSystems
ALGM
$6.67B
$7.51M 1.65%
+107,865
New +$5.05M
MIRM icon
8
Mirum Pharmaceuticals
MIRM
$5.94B
$7.41M 1.63%
63,295
+24,290
+62% +$2.44M
FROG icon
9
JFrog
FROG
$12.2B
$7.33M 1.61%
80,655
-38,655
-32% -$2.51M
CRS icon
10
Carpenter Technology
CRS
$23.6B
$7.2M 1.58%
11,665
-9,310
-44% -$4.38M
DY icon
11
Dycom Industries
DY
$8.88B
$7.16M 1.58%
14,170
-2,835
-17% -$1.24M
KRYS icon
12
Krystal Biotech
KRYS
$10.4B
$7.08M 1.56%
19,050
+535
+3% +$160K
CVLT icon
13
Commault Systems
CVLT
$5.65B
$7.04M 1.55%
+49,640
New +$5.33M
ADPT icon
14
Adaptive Biotechnologies
ADPT
$4.02B
$6.97M 1.53%
+325,155
New +$4.98M
ZETA icon
15
Zeta Global
ZETA
$7.67B
$6.92M 1.52%
351,415
+200,480
+133% +$3.72M
RBC icon
16
RBC Bearings
RBC
$15.8B
$6.78M 1.49%
10,531
-2,215
-17% -$1.32M
TVTX icon
17
Travere Therapeutics
TVTX
$6.19B
$6.76M 1.49%
119,005
+70,820
+147% +$3.14M
ENVA icon
18
Enova International
ENVA
$5.79B
$6.66M 1.46%
27,655
+1,815
+7% +$312K
FORM icon
19
FormFactor
FORM
$7.94B
$6.63M 1.46%
41,430
+12,125
+41% +$1.61M
UCTT
20
Ultra Clean Holdings
UCTT
$3.15B
$6.6M 1.45%
46,285
-13,550
-23% -$1.19M
PVLA
21
Palvella Therapeutics
PVLA
$2.16B
$6.57M 1.44%
42,975
+1,530
+4% +$186K
SIMO icon
22
Silicon Motion
SIMO
$8.33B
$6.53M 1.44%
19,600
-5,685
-22% -$1.32M
MOD icon
23
Modine Manufacturing
MOD
$9.43B
$6.4M 1.41%
23,975
-13,290
-36% -$3.5M
CROX icon
24
Crocs
CROX
$5.86B
$6.37M 1.4%
+52,840
New +$5.77M
GRDN
25
Guardian Pharmacy Services
GRDN
$2.35B
$6.37M 1.4%
152,025
-36,125
-19% -$1.4M

Similar funds

Lisanti Capital Growth's Q2 2026 Portfolio in Review

As of Q2 2026, Lisanti Capital Growth held 153 positions worth $455M, up 15% from $397M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $82.2M in Q2 2026, closing 44 positions and reducing 37 holdings. Its most notable exit was Five Below, an estimated $9.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Xometry worth $9.74M.

  • Lisanti Capital Growth's largest Q2 2026 buy was Xometry: 100,880 shares worth $9.74M.
  • Lisanti Capital Growth added most to Hinge Health in Q2 2026, an estimated $4.34M increase.
  • Lisanti Capital Growth's biggest Q2 2026 reduction was Sterling Infrastructure, cutting an estimated $10.7M.
  • Lisanti Capital Growth fully exited Five Below in Q2 2026, selling an estimated $9.74M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $455M portfolio in Q2 2026.
  • Lisanti Capital Growth opened 50 new positions and closed 44 in Q2 2026.
  • Lisanti Capital Growth's portfolio value rose 15% quarter-over-quarter to $455M.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.